Home › Funds › Ally Bridge Group (NY) LLC › OVID
Ally Bridge Group (NY) LLC position in OVID
OVID THERAPEUTICS INC · Health Care
Ally Bridge Group (NY) LLC reported holding 624,561 shares of OVID (OVID THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 1.49% of its reported portfolio and ranking #22 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's OVID position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in OVID in Q4 2025 at 1,785,000 shares (US$2.9M). The position peaked in Q1 2026 at 2,818,459 shares, worth US$6.3M. Across 3 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 624,561 shares valued at US$1.7M — a reduction of -2,193,898 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares rose 21% over the following quarter), a 78% trim in Q2 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.78M | $2.91M | New |
| Q1 2026 | 2.82M | $6.26M | Add |
| Q2 2026 | 624.56K | $1.68M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OVID and 13F data
OVID (OVID THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OVID
- Affinity Asset Advisors, LLC 10.14M sh · $27.29M · Q2 2026
- ADAR1 Capital Management, LLC 7.42M sh · $19.95M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 3.10M sh · $8.34M · Q2 2026
- STEMPOINT CAPITAL LP 2.42M sh · $6.50M · Q2 2026
- Ikarian Capital, LLC 2.27M sh · $6.11M · Q2 2026
- Propel Bio Management, LLC 1.12M sh · $3.00M · Q2 2026
- Rosalind Advisors, Inc. 1.11M sh · $2.98M · Q2 2026
- Sio Capital Management, LLC 1.01M sh · $2.70M · Q2 2026
- Saturn V Capital Management LP 663.06K sh · $1.78M · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held OVID?
Ally Bridge Group (NY) LLC has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Ally Bridge Group (NY) LLC's current position in OVID?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 624.56K shares of OVID (OVID THERAPEUTICS INC), valued at $1.68M, representing 1.49% of its reported portfolio and ranking #22.
Has Ally Bridge Group (NY) LLC been buying or selling OVID?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in OVID. The position peaked in Q1 2026 at 2.82M shares.
Which other funds hold OVID?
Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.